The Food and Drug Administration (FDA) recently approved Dovato, the first comprehensive HIV treatment program for two drugs for people who have not been treated before.

According to a press release, the new medication is for people who have no knowledge or suspicion of resistance to therapy.

Currently, HIV-positive people who have never received antiretroviral treatment regimens with three medications are treated.

Why is Dovato important?

It offers the possibility that these people in a pill take their treatment with two medications. ViiV Healthcare has developed the medication.

"Having moderate treatment that uses fewer medications is beneficial for patients who may have problems taking several medications over a long period of time," said Dr. Debra Birnkrant, director of the FDA's antiviral department in the press release. .

However, this is not the first treatment with two anti-HIV drugs developed. There are 17 months that the FDA approved Juluca.

Author's Bio: 

Jolina is a medical practitioner and author in medrx